Calliditas Therapeutics AB Adjusted Weighted Average Shares
Calliditas Therapeutics AB reported Adjusted Weighted Average Shares of 53.69 million shares for the 3-month period ending 2024-06-30, per its 6-K filed 2024-08-13.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:AdjustedWeightedAverageShares · last filed 2024-08-13
- Calliditas Therapeutics AB adjusted weighted average shares for the quarter ending 2024-06-30 was 53.69M shares, a 0.03% increase year-over-year.
- Calliditas Therapeutics AB adjusted weighted average shares for the quarter ending 2023-06-30 was 53.67M shares, a 0.91% increase year-over-year.
- Calliditas Therapeutics AB adjusted weighted average shares for the quarter ending 2022-06-30 was 53.19M shares, a 6.50% increase year-over-year.
- Calliditas Therapeutics AB adjusted weighted average shares for the quarter ending 2022-03-31 was 52.38M shares, a 4.89% increase year-over-year.
| Period end | Adjusted Weighted Average Shares 3 month | Adjusted Weighted Average Shares 6 month | Adjusted Weighted Average Shares 12 month |
|---|---|---|---|
| 2024-06-30 | 53.69M shares 6-K · filed 2024-08-13 | 53.68M shares 6-K · filed 2024-08-13 | |
| 2023-12-31 | 53.67M shares 6-K · filed 2024-08-13 | ||
| 2023-06-30 | 53.67M shares 6-K · filed 2024-08-13 | 53.67M shares 6-K · filed 2024-08-13 | |
| 2022-12-31 | 53.02M shares 6-K · filed 2023-08-17 | ||
| 2022-06-30 | 53.19M shares 6-K · filed 2023-08-17 | 52.79M shares 6-K · filed 2023-08-17 | |
| 2022-03-31 | 52.38M shares 6-K · filed 2022-05-20 | ||
| 2021-12-31 | 50.83M shares 6-K · filed 2022-08-19 | ||
| 2021-06-30 | 49.94M shares 6-K · filed 2022-08-19 | 49.94M shares 6-K · filed 2022-08-19 | |
| 2021-03-31 | 49.94M shares 6-K · filed 2022-05-20 | ||
| 2020-12-31 | 44.87M shares 6-K · filed 2021-08-20 | ||
| 2020-06-30 | 40.92M shares 6-K · filed 2021-08-20 | 39.82M shares 6-K · filed 2021-08-20 |